Skip to main content
Erschienen in: Surgical Endoscopy 4/2008

01.04.2008

Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model

verfasst von: Camilo Boza, Michel Gagner, Nicolás Devaud, Alex Escalona, Rodrigo Muñoz, Monica Gandarillas

Erschienen in: Surgical Endoscopy | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Bariatric surgery has evolved into multiple forms in the last decades, combining food restriction and malabsorption. The aim of this study was to develop a new technique based on food restriction and early stimulation of the distal gut, thus maintaining the alimentary tract continuity.

Methods

Thirty-two Yorkshire pigs, weight 22.2 ± 5.4 kg (mean ± SD) were randomly assigned to four laparoscopic procedures: ileal transposition (IT, n = 8); sleeve gastrectomy with ileal transposition (SGIT, n = 8); Roux-en-Y gastric bypass (GBP, n = 8); sham operation (SHAM, n = 8). Firing 45-mm linear staplers over a 60-F bougie, resecting the greater curvature and fundus, constituted a sleeve gastrectomy. Ileal transposition was performed by isolating a 100-cm ileal segment proximal to the ileocecal valve and by dividing the proximal jejunum 15 cm distal to the ligament of Treitz and performing re-anastomosis. Gastric bypass consisted of creating a proximal gastric pouch and a 300 cm alimentary limb. Sham operation was performed by bowel transections and re-anastomosis in the ileum and proximal jejunum together with gastrotomy and closure. Animals were evaluated weekly for weight increase and food intake. We performed a logistic regression analysis to compare weight progression curves, and analysis of variance (ANOVA) and Bonferroni (Dunn) tests to detect differences in weight and food intake.

Results

We observed significant differences in mean weight after 18 weeks between SGIT (30.9 ± 13.4 kg) and SHAM (72.5 ± 10.7 kg) (p = 0.0002), and GBP (28.6 ± 2.5 kg) and SHAM (p = 0.0001), and IT (56.1 ± 13.4 kg) and SHAM (p = 0.0081). No differences were observed between RYGB and SGIT. We also observed significant differences in food intake (grams per day) in the third month between SGIT (1668 ± 677 g) versus SHAM (3252 ± 476 g) (p = 0.0006), and GBP (2011 ± 565 g) versus SHAM (p = 0.039). No differences were observed in food intake between SGIT and GBP.

Conclusion

SGIT proved to be as effective in the short term as GBP on weight progression with no bypass of the proximal gut.
Literatur
1.
Zurück zum Zitat Mun EC, Blackburn GL, Matthews JB (2001) Current status of medical and surgical therapy for obesity. Gastroenterology 120(3):669–81PubMedCrossRef Mun EC, Blackburn GL, Matthews JB (2001) Current status of medical and surgical therapy for obesity. Gastroenterology 120(3):669–81PubMedCrossRef
2.
Zurück zum Zitat Naslund E, Hellstrom PM, Kral JG (2001) The gut and food intake: an update for surgeons. J Gastrointest Surg 5(5):556–67PubMedCrossRef Naslund E, Hellstrom PM, Kral JG (2001) The gut and food intake: an update for surgeons. J Gastrointest Surg 5(5):556–67PubMedCrossRef
3.
Zurück zum Zitat Wynne K, Stanley S, Bloom S (2004) The gut and regulation of body weight. J Clin Endocrinol Metab 89(6):2576–82PubMedCrossRef Wynne K, Stanley S, Bloom S (2004) The gut and regulation of body weight. J Clin Endocrinol Metab 89(6):2576–82PubMedCrossRef
4.
Zurück zum Zitat Hung CC, Pirie F, Luan J, et al. (2004) Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes 53(9):2461–6PubMedCrossRef Hung CC, Pirie F, Luan J, et al. (2004) Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes 53(9):2461–6PubMedCrossRef
5.
Zurück zum Zitat Canbeyli RS, Koopmans HS (1984) The role of jejunal signals in the long-term regulation of food intake in the rat. Physiol Behav 33(6):945–50PubMedCrossRef Canbeyli RS, Koopmans HS (1984) The role of jejunal signals in the long-term regulation of food intake in the rat. Physiol Behav 33(6):945–50PubMedCrossRef
6.
Zurück zum Zitat Wren AM, Small CJ, Abbott CR, et al. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50(11):2540–7PubMedCrossRef Wren AM, Small CJ, Abbott CR, et al. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50(11):2540–7PubMedCrossRef
7.
Zurück zum Zitat Geloneze B, Tambascia MA, Pilla VF, et al. (2003) Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 13(1):17–22PubMedCrossRef Geloneze B, Tambascia MA, Pilla VF, et al. (2003) Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 13(1):17–22PubMedCrossRef
8.
Zurück zum Zitat Fruhbeck G, Diez-Caballero A, Gil MJ, et al. (2004) The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 14(5):606–12PubMedCrossRef Fruhbeck G, Diez-Caballero A, Gil MJ, et al. (2004) The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 14(5):606–12PubMedCrossRef
9.
Zurück zum Zitat Small CJ, Bloom SR (2004) Gut hormones and the control of appetite. Trends Endocrinol Metab 15(6):259–63PubMedCrossRef Small CJ, Bloom SR (2004) Gut hormones and the control of appetite. Trends Endocrinol Metab 15(6):259–63PubMedCrossRef
10.
Zurück zum Zitat Dakin CL, Small CJ, Batterham RL, et al. (2004) Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145(6):2687–95PubMedCrossRef Dakin CL, Small CJ, Batterham RL, et al. (2004) Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145(6):2687–95PubMedCrossRef
11.
Zurück zum Zitat Verdich C, Flint A, Gutzwiller JP, et al. (2001) A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86(9):4382–9PubMedCrossRef Verdich C, Flint A, Gutzwiller JP, et al. (2001) A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86(9):4382–9PubMedCrossRef
12.
Zurück zum Zitat Cohen MA, Ellis SM, Le Roux CW, et al. (2003) Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88(10):4696–701PubMedCrossRef Cohen MA, Ellis SM, Le Roux CW, et al. (2003) Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88(10):4696–701PubMedCrossRef
13.
Zurück zum Zitat Konturek SJ, Konturek JW, Pawlik T, Brzozowski T (2004) Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55(1Pt2):137–54PubMed Konturek SJ, Konturek JW, Pawlik T, Brzozowski T (2004) Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55(1Pt2):137–54PubMed
14.
Zurück zum Zitat Batterham RL, Cohen MA, Ellis SM, et al. (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349(10):941–8PubMedCrossRef Batterham RL, Cohen MA, Ellis SM, et al. (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349(10):941–8PubMedCrossRef
15.
Zurück zum Zitat Korner J, Bessler M, Cirilo L, Conwell I (2004) Effects of Roux-en-Y gastric bypass on fasting and postprandial concentrations of plasma ghrelin, PYY and insulin. J Clin Endocrinol Metab Online Korner J, Bessler M, Cirilo L, Conwell I (2004) Effects of Roux-en-Y gastric bypass on fasting and postprandial concentrations of plasma ghrelin, PYY and insulin. J Clin Endocrinol Metab Online
16.
Zurück zum Zitat Rubino F, Gagner M, Gentileschi P, et al. (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240(2):236–42PubMedCrossRef Rubino F, Gagner M, Gentileschi P, et al. (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240(2):236–42PubMedCrossRef
17.
Zurück zum Zitat Stoeckli R, Chanda R, Langer I, Keller U (2004) Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 12(2):346–50PubMed Stoeckli R, Chanda R, Langer I, Keller U (2004) Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 12(2):346–50PubMed
18.
Zurück zum Zitat Adami GF, Cordera R, Marinari G, et al. (2003) Plasma ghrelin concentratin in the short-term following biliopancreatic diversion. Obes Surg 13(6):889–92PubMedCrossRef Adami GF, Cordera R, Marinari G, et al. (2003) Plasma ghrelin concentratin in the short-term following biliopancreatic diversion. Obes Surg 13(6):889–92PubMedCrossRef
19.
Zurück zum Zitat Frezza EE (2004) Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg 14(7):999–1005PubMedCrossRef Frezza EE (2004) Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg 14(7):999–1005PubMedCrossRef
20.
21.
Zurück zum Zitat Mason EE (1999) Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 9(3):223–8PubMedCrossRef Mason EE (1999) Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 9(3):223–8PubMedCrossRef
22.
Zurück zum Zitat Patriti A, Facchiano E, Sanna A, et al. (2004) The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 14(6):840–8PubMedCrossRef Patriti A, Facchiano E, Sanna A, et al. (2004) The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 14(6):840–8PubMedCrossRef
23.
Zurück zum Zitat Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239(1):1–11PubMedCrossRef Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239(1):1–11PubMedCrossRef
24.
Zurück zum Zitat Naslund E, Backman L, Holst JJ, et al. (1998) Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8(3):253–60PubMedCrossRef Naslund E, Backman L, Holst JJ, et al. (1998) Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8(3):253–60PubMedCrossRef
25.
Zurück zum Zitat Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13(6):861–4PubMedCrossRef Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13(6):861–4PubMedCrossRef
26.
Zurück zum Zitat Koopmans HS, Sclafani A, Fichtner C, Aravich PF (1982) The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am J Clin Nutr 35(2):284–93PubMed Koopmans HS, Sclafani A, Fichtner C, Aravich PF (1982) The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am J Clin Nutr 35(2):284–93PubMed
27.
Zurück zum Zitat Koopmans HS, Ferri GL, Sarson DL, et al. (1984) The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats. Physiol Behav 33(4):601–9PubMedCrossRef Koopmans HS, Ferri GL, Sarson DL, et al. (1984) The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats. Physiol Behav 33(4):601–9PubMedCrossRef
28.
Zurück zum Zitat Strader AD, Vahl TP, Jandacek RJ, et al. (2005) Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in the rat. Am J Physiol Endocrinol Metab 288(2):E447–53PubMedCrossRef Strader AD, Vahl TP, Jandacek RJ, et al. (2005) Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in the rat. Am J Physiol Endocrinol Metab 288(2):E447–53PubMedCrossRef
29.
Zurück zum Zitat Ferri GL, Koopmans HS, Ghatei MA, et al. (1983) Ileal enteroglucagon cells after ileal-duodenal transposition in the rat. Digestion 26(1):10–6PubMedCrossRef Ferri GL, Koopmans HS, Ghatei MA, et al. (1983) Ileal enteroglucagon cells after ileal-duodenal transposition in the rat. Digestion 26(1):10–6PubMedCrossRef
30.
Zurück zum Zitat De Paula AL, Macedo AL, Prudente AS, et al. (2006) Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)–pilot study of a new operation. Surg Obes Relat Dis 2(4):464–7PubMedCrossRef De Paula AL, Macedo AL, Prudente AS, et al. (2006) Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)–pilot study of a new operation. Surg Obes Relat Dis 2(4):464–7PubMedCrossRef
31.
Zurück zum Zitat Langer FB, Reza Hoda MA, Bohdjalian A, et al. (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15(7):1024–9PubMedCrossRef Langer FB, Reza Hoda MA, Bohdjalian A, et al. (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15(7):1024–9PubMedCrossRef
32.
Zurück zum Zitat Melissas J, Koukouraki S, Askoxylakis J, et al. (2007) Sleeve gastrectomy: a restrictive procedure? Obes Surg 17(1):57–62PubMedCrossRef Melissas J, Koukouraki S, Askoxylakis J, et al. (2007) Sleeve gastrectomy: a restrictive procedure? Obes Surg 17(1):57–62PubMedCrossRef
33.
Zurück zum Zitat Gagner M (2005) La transposition iléale avec ou sans gastrectomie par laparoscopie chez l’homme (TIG). J Coeliochirurgie 54:4–9 Gagner M (2005) La transposition iléale avec ou sans gastrectomie par laparoscopie chez l’homme (TIG). J Coeliochirurgie 54:4–9
Metadaten
Titel
Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model
verfasst von
Camilo Boza
Michel Gagner
Nicolás Devaud
Alex Escalona
Rodrigo Muñoz
Monica Gandarillas
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 4/2008
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-007-9685-y

Weitere Artikel der Ausgabe 4/2008

Surgical Endoscopy 4/2008 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.